INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

CAPÍTULO VIII
244
Italiano para el Estudio de la Supervivencia en el Infarto de Miocardio Prevenzione.
Determinants of late-onset heart failure in myocardial infarction survivors: GISSI
Prevenzione trial results. Rev Esp Cardiol. 2005 Nov;58(11):1266-72.
331. Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of
cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011
Jan;16(1):13-21.
332. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling concepts and clinical implications: a
consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol.
2000 Mar 1;35(3):569-82.
333. Barrabés JA, Barba I. Medium-term changes in myocardial perfusion and ventricular
remodeling following acute myocardial infarction. Rev Esp Cardiol. 2007 May;60(5):468-
70.
334. Roig Minguell E. Utilidad clínica de los marcadores neurohormonales en la insuficiencia
cardíaca. Rev Esp Cardiol. 2004 Apr;57(4):347-56. Review.
335. Domínguez Rodríguez A, Abreu González P, García González MJ, Ferrer Hita J. Association
between serum interleukin 10 level and development of heart failure in acute myocardial
infarction patients treated by primary angioplasty. Rev Esp Cardiol. 2005 Jun;58(6):626-
30.
336. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol. 1997
Dec 4;80(11A):15L-25L.
337. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV. Glycemic control and
heart failure among adult patients with diabetes. Circulation. 2001 Jun 5;103(22):2668-
73.
338. Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K,
ONTARGET/TRANSCEND Investigators: Glucose levels predict hospitalization for
congestive heart failure in patients at high cardiovascular risk. Circulation. 2007 Mar
20;115(11):1371-5.
339. Pazin-Filho A, Kottgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD, Coresh J. HbA
1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in
Communities (ARIC) study. Diabetologia. 2008 Dec;51(12):2197-204.
340. Matsushita K, Blecker S, Pazin-Filho A, Bertoni A, Chang PP, Coresh J, Selvin E. The
association of hemoglobin a1c with incident heart failure among people without diabetes:
the atherosclerosis risk in communities study. Diabetes. 2010 Aug;59(8):2020-6.
341. Wolffenbuttel BH, Giordano D, Founds HW, Bucala R. Long-term assessment of glucose
control by haemoglobin-AGE measurement. Lancet. 1996 Feb 24;347(9000):513-5.
342. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold
for the macrovascular complications of diabetes and beyond. Circ Res. 2003 Dec
12;93(12):1159-69
343. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the
Redefinition of Myocardial Infarction. Universal definition of myocardial infarction.
Circulation. 2007 Nov 27;116(22):2634-53.
344. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KA,
Hasdai D, Ohman EM, Wallentin L, Wijns W. Task Force for Diagnosis and Treatment of
Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of
Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation
acute coronary syndromes. Eur Heart J. 2007 Jul;28(13):1598-660.
345. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K,
Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis
M; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial
infarction in patients presenting with persistent ST-segment elevation: the Task Force on
the Management of ST-Segment Elevation Acute Myocardial Infarction of the European
Society of Cardiology. Eur Heart J. 2008 Dec;29(23):2909-45.